Invention Application
- Patent Title: ENHANCER OF SURVIVAL OF TRANSPLANTED ORGAN
- Patent Title (中): 运输机构存货增值
-
Application No.: US15064884Application Date: 2016-03-09
-
Publication No.: US20160206582A1Publication Date: 2016-07-21
- Inventor: Ko RII , Kiwamu TAKAHASHI , Naomi HAGA , Fuminori ABE , Tohru TANAKA , Motowo NAKAJIMA , Hidenori ITO
- Applicant: SBI Pharmaceuticals Co., Ltd. , National Center for Child Health and Development
- Applicant Address: JP Tokyo JP Tokyo
- Assignee: SBI Pharmaceuticals Co., Ltd.,National Center for Child Health and Development
- Current Assignee: SBI Pharmaceuticals Co., Ltd.,National Center for Child Health and Development
- Current Assignee Address: JP Tokyo JP Tokyo
- Priority: JP2011-225384 20111012; JP2012-157374 20120713
- Main IPC: A61K31/197
- IPC: A61K31/197 ; A61K33/26 ; A61K35/17

Abstract:
The present invention provides an agent for promoting graft survival which can suppress rejection without use of existing immunosuppressants, an organ preservation solution capable of maintaining the freshness of an organ excised from a donor, and the like. An agent for promoting graft survival or an organ preservation solution is prepared, which comprises 5-aminolevulinic acid (ALA) or a derivative thereof, or a salt of ALA or the derivative and an iron compound as active ingredients. Preferable examples of the ALAs can include ALA and various esters such as methyl ester, ethyl ester, propyl ester, butyl ester, and pentyl ester of ALA, and their hydrochlorides, phosphates, and sulfates. Preferable examples of the iron compound can include sodium ferrous citrate.
Public/Granted literature
- US09937138B2 Enhancer of survival of transplanted organ Public/Granted day:2018-04-10
Information query
IPC分类: